Associate
Ken Guerra focuses on patent litigation and strategic counseling, primarily representing pharmaceutical and biotechnology innovators before U.S. district courts, the U.S. Court of Appeals for the Federal Circuit, and the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). He has particular experience with litigations arising under the Biologics Price Competition and Innovation Act (BPCIA) and litigating Abbreviated New Drug Application (ANDA) cases. Ken also handles matters related to artificial intelligence (AI) technologies in the pharmaceutical industry.
Ken’s litigation experience covers all aspects of trial and appeal preparation, including conducting discovery and handling day-to-day litigation activities. He is actively involved in all phases of litigation, including pre-litigation analysis, fact discovery, and expert discovery. Cases Ken has worked on have been recognized by legal news media outlets as substantial victories before U.S. district courts and the U.S. Court of Appeals for the Federal Circuit.
Before law school, Ken conducted research at the Indiana University School of Medicine, exploring the biochemical pathways for the progression of emphysema in HIV infected endothelial cells, identifying Endothelial Monocyte Activating Polypeptide II (EMAP II) as a key molecule required for the progression of emphysema. Ken also worked in the Indiana University Department of Chemistry, exploring the physical properties of lipid vesicles stabilized by Janus particles and their uptake in a cellular environment to fabricate smart drug-delivery carriers.
Ken has been recognized on the Capital Pro Bono Honor Roll for his work serving honorably discharged veterans before the U.S. Court of Appeals for the Federal Circuit and U.S. Court of Appeals for Veterans Claims. He proudly co-led the Finnegan LGBTQ+ Affinity Group. Ken currently serves as a founding member of the Hispanic National Bar Association’s Special Committee on Artificial Intelligence, while also holding additional leadership positions within the organization as well as within the D.C. Bar communities.
Mitsubishi Tanabe Pharma Corporation v. Shanghai Auzone Biological Technology Co., Ltd et al.
Representing Mitsubishi Tanabe Pharma in litigation matters related to Radicava ORS (edaravone) used to treat patients with amyotrophic lateral sclerosis (ALS).
2:25-cv-03326, D.N.J., Judge Cecchi
1:23-cv-00759, D. Del., Judges Burke, Connolly, Hall
1:24-cv-01423, D. Del., Judge Hall
1:24-cv-00549, D. Del., Judge Hall
Teva Pharmaceuticals International GmbH v. Eli Lilly and Company
IPR2022-00738, -00739, -00796, PTAB, Judges Cotta, Wisz, Worth
1:21-cv-10954, D. Mass., Judge Burroughs
BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al.
1:18-cv-01395, D. Del., Judge Connolly
Maglula, Ltd. v. Amazon.Com, Inc. et al
1:19-cv-01570, E.D. Va., Judge O'Grady
Conference
2024 Hispanic National Bar Association Corporate Counsel Conference 2024 Hispanic National Bar Association Corporate Counsel Conference
March 20-22, 2024
Seattle
Webinar
LEAP the Barriers to PTAB Oral Advocacy LEAP the Barriers to PTAB Oral Advocacy
February 29, 2024
Webinar
Panel Discussion
A Conversation with D.C. Attorney General Brian Schwalb A Conversation with D.C. Attorney General Brian Schwalb
February 20, 2024
Washington
Conference
2023 Lavender Law Conference & Career Fair 2023 Lavender Law Conference & Career Fair
July 24-26, 2023
Chicago
Federal Circuit IP Blog
Will 2023 Be the Year of § 112 at the Supreme Court? Will 2023 Be the Year of § 112 at the Supreme Court?
December 7, 2022
Conference
2022 HNBA Annual Convention 2022 HNBA Annual Convention
September 7-9, 2022
Washington, DC
Award/Ranking
61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll 61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll
May 7, 2026
Award/Ranking
56 Finnegan Attorneys Recognized on the 2024 Capital Pro Bono Honor Roll 56 Finnegan Attorneys Recognized on the 2024 Capital Pro Bono Honor Roll
April 24, 2025
DC BarAward/Ranking
60 Finnegan Attorneys Named to 2023 Capital Pro Bono Honor Roll 60 Finnegan Attorneys Named to 2023 Capital Pro Bono Honor Roll
May 15, 2024
Commentary
Deep in the Trenches: New Attorneys Define Their Success Deep in the Trenches: New Attorneys Define Their Success
January/February 2024
Washington LawyerCommentary
The 2023 WIPL Awards: Law Firm Lifetime Achievement The 2023 WIPL Awards: Law Firm Lifetime Achievement
November 20, 2023
Law.comDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.